Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
September 12, 2024	EFFECT	EFFECT	9999999995-24-002822.pdf 9999999995-24-002822.rtf 9999999995-24-002822.xls View HTML
September 10, 2024	CORRESP	CORRESP	0001628280-24-040031.pdf 0001628280-24-040031.rtf 0001628280-24-040031.xls View HTML
September 9, 2024	UPLOAD	UPLOAD	0000000000-24-010161.pdf 0000000000-24-010161.rtf View HTML
September 3, 2024	S-3	Simplified registration form	0001628280-24-039115.pdf 0001628280-24-039115.rtf 0001628280-24-039115.xls View HTML
August 8, 2024	8-K	Report of unscheduled material events or corporate event	0001517022-24-000065.pdf 0001517022-24-000065.rtf 0001517022-24-000065.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 8, 2024	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-24-035879.pdf 0001628280-24-035879v2.rtf 17.9 MB 0001628280-24-035879.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
July 11, 2024	8-K	Report of unscheduled material events or corporate event	0001517022-24-000061.pdf 0001517022-24-000061.rtf 0001517022-24-000061.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
July 2, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-005516.pdf 0001562180-24-005516.rtf 0001562180-24-005516.xls View HTML
June 26, 2024	3	Initial filing by director officer or owner of more than ten percent	0001562180-24-005321.pdf 0001562180-24-005321.rtf 0001562180-24-005321.xls View HTML
June 24, 2024	8-K	Report of unscheduled material events or corporate event	0001517022-24-000059.pdf 0001517022-24-000059.rtf 0001517022-24-000059.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax